The study began with a straightforward but demanding measurement task. The researchers acquired high-resolution T1-weighted magnetic resonance imaging scans from 73 patients with sporadic ALS and 70 healthy controls, then used the Desikan-Killiany-Tourville atlas to parcellate the cortex into defined regions of interest. For each region they quantified two separate structural phenotypes: cortical surface area, which reflects the sheet-like expansion of the cortex during development, and cortical thickness, which is more closely tied to the density and health of neurons within the cortical column. This distinction matters because surface area and thickness are governed by partly independent genetic programs, and treating them as a single lumped measure can obscure the biology underneath.

The comparisons revealed precise, statistically robust alterations. Patients showed significantly reduced surface area in the left precentral gyrus, the strip of cortex that houses the primary motor neurons whose degeneration drives the muscle wasting and weakness characteristic of ALS. They also showed decreased cortical thickness in the left frontal pole, a region implicated in the cognitive and behavioral changes that frequently accompany the disease, including the frontotemporal dementia spectrum that overlaps clinically with a subset of ALS cases. Both findings survived correction for multiple comparisons across the full cortical parcellation, with false discovery rate adjusted p-values of 0.025, suggesting that the structural signature is not a statistical artifact of scanning dozens of regions simultaneously.

With the anatomical targets established, the team asked a harder question: does the shape of the cortex influence ALS risk, or does the disease reshape the cortex? To address the direction of the relationship, they turned to two-sample Mendelian randomization, a technique that uses genetic variants as naturally randomized instruments to probe causality. The analysis identified nominal associations between ALS risk and several cortical structural phenotypes, including surface area of the paracentral lobule and thickness of the frontal pole. While nominal rather than definitive, these associations are consistent with a model in which cortical architecture and disease susceptibility are intertwined, with certain structural configurations marking regions that are intrinsically more vulnerable to the ALS process.

The next step was the study’s methodological centerpiece: coupling the imaging signatures to gene expression. The researchers drew on the Allen Human Brain Atlas, a postmortem resource that maps the expression of thousands of genes across hundreds of cortical sampling sites, and used partial least squares regression to identify transcriptional programs whose spatial distribution across the cortex mirrors the pattern of surface area and thickness alteration in ALS. They complemented this with a region-wise differential expression analysis to derive intersect gene sets. The result was a catalogue of 215 genes tied to surface area alterations and 979 genes tied to thickness alterations, each representing a molecular fingerprint of the regions that falter in ALS.

Functional enrichment analyses gave these gene sets biological texture. Both sets were enriched in synaptic processes and neuroactive ligand-receptor interaction pathways, pointing to the well-established role of excitatory synaptic dysfunction and glutamatergic signaling in motor neuron degeneration. But the cell-type analysis, performed using expression-weighted cell-type enrichment, produced the study’s most intriguing division. Genes associated with surface area alterations were preferentially expressed in oligodendrocyte-related cell types, the myelin-forming glia that wrap axons and support the metabolic demands of long-range projection neurons. Genes associated with thickness alterations, by contrast, showed astrocyte-related enrichment, implicating the star-shaped support cells that regulate neurotransmitter clearance, blood-brain barrier integrity and metabolic coupling at synapses.

To move from spatial correlation to molecular prioritization, the team deployed summary-data-based Mendelian randomization, or SMR, which integrates genome-wide association study data for ALS with quantitative trait loci that link genetic variants to gene expression and DNA methylation. This approach tests whether the genetic signal associated with a structural phenotype is mediated by altered expression of a nearby gene, effectively triangulating among imaging, genetics and transcriptomics. The analysis nominated two candidate genes: MOBP, associated with the surface area alteration pattern, and ZNHIT3, associated with the thickness pattern. MOBP encodes a myelin-associated protein expressed almost exclusively in oligodendrocytes, fitting neatly with the oligodendrocyte enrichment of the surface area gene set. ZNHIT3, a component of chromatin-remodeling machinery with roles in RNA polymerase transcription, fits less obviously but intriguingly into the astrocyte story.

Independent evidence came from public single-cell RNA sequencing datasets derived from ALS cases carrying the C9orf72 repeat expansion, the most common genetic cause of the disease. In those data, MOBP expression differed significantly in oligodendrocytes, and ZNHIT3 expression was significantly lower in astrocytes, both with p-values below 0.001. The convergence is notable: two genes prioritized through a purely statistical pipeline built on sporadic ALS imaging showed cell-type-specific expression changes in an independent, genetically distinct form of the disease. That cross-validation across modalities and patient populations strengthens the argument that oligodendrocyte dysfunction and astrocyte dysfunction contribute in parallel, and through partly separable molecular routes, to the regional cortical vulnerability observed on MRI.

The findings arrive amid a broader shift in neuroscience toward multimodal data integration. Individual technologies, whether MRI, bulk transcriptomics or single-cell sequencing, each capture only a slice of a disease process that unfolds across scales from molecules to circuits to behavior. By anchoring the analysis to a measurable clinical phenotype, namely region-specific cortical atrophy, and then triangulating across four independent data layers, the study demonstrates a template that could be applied to other neurodegenerative conditions, including Alzheimer’s disease, frontotemporal dementia and Parkinson’s disease, where regional vulnerability is equally striking and equally unexplained. The same framework could also help reconcile why some ALS patients present with pure motor syndromes while others develop early cognitive impairment, potentially reflecting distinct molecular cascades in motor versus frontal cortex.

The authors are careful to frame the work as hypothesis-generating rather than definitive. The imaging cohort was modest in size, the Mendelian randomization associations were nominal, the transcriptomic coupling rests on postmortem atlas data from donors without ALS, and the single-cell evidence comes from a different ALS genotype. Future longitudinal studies tracking cortical structure in at-risk individuals, and experimental models testing whether MOBP and ZNHIT3 perturbation genuinely alters neuronal survival, will be needed to validate biological relevance. Still, by converting an anatomical observation into a shortlist of testable molecular suspects rooted in specific glial cell types, the study offers ALS researchers something the field has lacked: a concrete, data-driven entry point into the question of why the cortex fails where it does, and a roadmap for how imaging genetics can accelerate the search for therapeutic targets in one of medicine’s most relentless diseases.

Subject of Research: Molecular mechanisms of region-specific cortical vulnerability in amyotrophic lateral sclerosis

Article Title: Integrating neuroimaging, transcriptomics and single-cell sequencing identifies candidate molecular features of cortical vulnerability in amyotrophic lateral sclerosis

Article References: Luan, J., Shan, D., Yun, Y., Wang, Y., Ma, M., Wang, H., Ji, X., Jiao, Y., Tang, Y., Li, J., Zhan, Z., Sun, X., Gao, N., Yan, C., Liu, F., Liu, S., & Yu, D. (2026). Integrating neuroimaging, transcriptomics and single-cell sequencing identifies candidate molecular features of cortical vulnerability in amyotrophic lateral sclerosis. BMC Medicine. https://doi.org/10.1186/s12916-026-05247-3

Image Credits: AI Generated

DOI: 10.1186/s12916-026-05247-3

Keywords: amyotrophic lateral sclerosis, cortical thickness, cortical surface area, imaging transcriptomics, Mendelian randomization, SMR, single-cell RNA sequencing, oligodendrocytes, astrocytes, MOBP, ZNHIT3, motor cortex

The research, led by Lubin Gou and Junqiang Lei of the First Hospital of Lanzhou University and Lanzhou University’s First Clinical Medical College, focused on patients with liver cirrhosis without overt hepatic encephalopathy, a stage abbreviated LC-nOHE. This is the window in which the disease has already compromised liver function but has not yet produced the confusion, disorientation, and personality changes that define overt hepatic encephalopathy. Understanding what happens in the brain during this silent phase is critical, because it may reveal the earliest opportunities for intervention before irreversible damage takes hold.

The team recruited 86 patients with liver cirrhosis but no overt encephalopathy, along with 62 healthy controls, and acquired high-resolution three-dimensional T1-weighted magnetic resonance images of every participant’s brain. From these scans, the researchers extracted the volume of the thalamus and three distinct measures of cortical shape: cortical thickness, sulcal depth, and fractal dimension, a measure of the complexity of the brain’s folded surface. Rather than examining these features in isolation, the investigators constructed structural covariance networks, mathematical maps in which brain regions are connected if their anatomical features covary across individuals. Such networks are widely used as proxies for coordinated maturational and degenerative processes, offering a window into how brain regions change together as a system.

The results were striking at multiple levels. Compared with healthy controls, patients with cirrhosis showed enlargement of the thalamus alongside a broad range of cortical morphological abnormalities. At the level of whole-network organization, the thalamo-cortical structural covariance networks of patients displayed reduced segregation, meaning the brain’s specialized modules were less clearly differentiated, and decreased integration, meaning efficient communication across the network was impaired. These two properties, segregation and integration, are hallmarks of a healthy, well-organized brain, and their simultaneous deterioration suggests a fundamental disruption of the architecture that supports cognition.

Zooming in on individual network nodes, the researchers found that the centrality of three regions was significantly reduced in patients: the thalamus itself, the supramarginal gyrus, and the insula. Each of these regions plays a recognizable role in the syndrome. The thalamus relays sensory and motor signals to the cortex and regulates consciousness and alertness; the supramarginal gyrus contributes to language and spatial cognition; and the insula supports interoception and awareness of the body’s internal state. Reduced centrality in these hubs indicates that they had lost influence within the network, becoming less connected to the rest of the brain’s structural architecture.

Perhaps the most clinically significant finding was the relationship between brain changes and liver function. The degree centrality of the thalamus was negatively correlated with liver function measures, meaning that the worse the liver was performing, the more the thalamus had lost its position within the brain’s structural network. This correlation ties the brain imaging directly to the severity of liver disease and supports the idea that the thalamus sits at the front line of the liver-brain axis, the pathway by which hepatic dysfunction, circulating toxins such as ammonia, and systemic inflammation are translated into neural injury.

To move beyond correlation and probe causality, the team applied a technique called causal analysis of structural covariance networks, or CaSCN. This approach examines how changes in one brain region’s morphology relate to changes in others across the progression of disease, allowing researchers to ask which region leads and which follows. The analyses demonstrated that thalamus volume had causal effects on the alterations of cortical morphology as liver dysfunction progressed. In other words, the data are consistent with a model in which the thalamus is not merely another victim of cirrhosis but an active driver, propagating structural changes outward to the cortical regions with which it is connected.

The study then took an unusual additional step: linking the brain imaging to genomics through imaging transcriptomics. Using normative gene-expression profiles from the Allen Human Brain Atlas, the researchers evaluated whether the spatial pattern of causal effects across the cortex overlapped with the spatial distribution of specific genes. It did. The pattern of causal path coefficients was spatially correlated with the expression of particular genes in the normative atlas, suggesting that the cortical regions most vulnerable to thalamus-driven change are also those with distinctive molecular signatures. Gene ontology analyses pointed toward enrichment in biological processes, molecular functions, and cellular components that may help explain why some cortical areas are preferentially affected while others are relatively spared.

Taken together, the findings provide a comprehensive, multilevel view of how the thalamo-cortical circuit becomes progressively vulnerable in liver cirrhosis before overt encephalopathy appears. The enlargement of the thalamus, consistent with processes such as edema or glial changes reported in prior literature on hepatic encephalopathy, appears to initiate a cascade that erodes the segregation and integration of the entire structural network, strips key hubs of their centrality, and reshapes the cortex in patterns governed partly by underlying gene expression. Because the thalamus’s network position tracks liver function, measures of thalamo-cortical network integrity could potentially serve as imaging biomarkers for identifying patients at risk of progressing to overt hepatic encephalopathy, enabling earlier monitoring and treatment.

The authors emphasize that these findings offer a potential mechanism-driven framework for understanding the earliest brain consequences of liver disease, one that connects organ function, network neuroscience, and transcriptomics within a single analytical pipeline. The work was supported by the Lanzhou University First Affiliated Hospital Foundation and the Science and Technology Department of Gansu Province, and it was approved by the Institutional Ethics Committee of the First Hospital of Lanzhou University. As cirrhosis continues to affect millions worldwide, studies like this one bring clinicians closer to detecting, and perhaps preventing, the neurological toll of liver disease before it announces itself in the clinic.

Subject of Research: Structural covariance network alterations of the thalamo-cortical circuit in liver cirrhosis patients without overt hepatic encephalopathy

Article Title: Multilevel structural covariance network alterations of thalamo-cortical circuit in liver cirrhosis patients without overt hepatic encephalopathy: associations with liver function and imaging transcriptomics

Article References: Gou, L., Ren, H., Xu, W., Gao, Y., Wang, S., Zhang, Y., Dou, Y., & Lei, J. (2026). Multilevel structural covariance network alterations of thalamo-cortical circuit in liver cirrhosis patients without overt hepatic encephalopathy: associations with liver function and imaging transcriptomics. BMC Medical Imaging. https://doi.org/10.1186/s12880-026-02790-6

Image Credits: AI Generated

DOI: 10.1186/s12880-026-02790-6

Keywords: liver cirrhosis, hepatic encephalopathy, thalamus, thalamo-cortical circuit, structural covariance network, MRI, liver-brain axis, imaging transcriptomics, cortical thickness, liver function, neuroimaging, Allen Human Brain Atlas